Myopic choroidal neovascularization (mCNV) is a common, vision-threatening complication of pathological myopia, or severe nearsightedness.1 If left untreated, mCNV can lead to legal blindness.1
A Vision-
Threatening
Condition
mCNV is a severe, vision-threatening complication of pathological myopia.2
-
9.6 MILLION
-
41,000+
~30% of people with mCNV in one eye will develop mCNV in their other eye within 8 years2
Effect On Vision
When untreated, 89% of people with mCNV have a visual acuity of 20/200 or worse (legal blindness) after 5 years.4 Healthy vision is 20/20
How Does mCNV Affect Your Eye?1
As a result of severe nearsightedness, new, abnormal blood vessels grow directly into the retina
These vessels can break and leak blood or fluid into the retina. This leakage can cause irreversible central vision loss
Signs and Symptoms1
A RAPID PROGRESSION OF CENTRAL VISION LOSS
(within a day or a few weeks)
BLURRED VISION
DISTORTION OF OBJECTS AND LINES
DIFFICULTY DISTINGUISHING BETWEEN COLORS
mCNV Risk Factors
GENDER
Women at a 2x higher risk3
AGE
Most commonly, people between 45-64 years old3
RACE
More common in people of East Asian descent1
PEOPLE WHO HAVE PATHOLOGICAL MYOPIA1
Annual Dilated
Eye Exam
Visit an eye doctor for a regular dilated eye exam. It’s the best way to help detect changes in vision
- National Eye Institute. Facts About Myopia. Available at: https://nei.nih.gov/health/errors/myopia. Accessed June 16, 2016.
- Mones JM, et al. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye. 2009;23:1275-1281.
- Willis J, Vitale S, et al. The Prevalence of Myopic Choroidal Neovascularization in the United States. Ophthalmology, 2016;123:1771-1782.
- Ohno-Matsui, K. (2011, July/August). Retina Today – GLOBAL PERSPECTIVES: Advances in Diagnosis and Treatment of Pathologic Myopia. Available at: http://retinatoday.com/2011/08/global-perspectives-advances-in-diagnosis-andtreatment-of-pathologic-myopia/. Accessed November 22, 2016.
LUC/110916/0130